The Current Ratio as of September 2024 (TTM) for Anavex Life Sciences Corp. (AVXL) is 12.04

According to Anavex Life Sciences Corp.’s latest financial reports and current stock price. The company's current Current Ratio is 12.04. This represents a change of -6.16% compared to the average of 12.83 of the last 4 quarters.

Anavex Life Sciences Corp. (AVXL) Historical Current Ratio (quarterly & annually)

How has AVXL Current Ratio performed in the past?

The mean historical Current Ratio of Anavex Life Sciences Corp. over the last ten years is 7.99. The current 12.04 Current Ratio has changed 14.97% with respect to the historical average. Over the past ten years (40 quarters), AVXL's Current Ratio was at its highest in in the March 2022 quarter at 19.86. The Current Ratio was at its lowest in in the September 2016 quarter at 2.96.

Anavex Life Sciences Corp. (AVXL) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Anavex Life Sciences Corp. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Anavex Life Sciences Corp. (AVXL) Average Current Ratio

How has AVXL Current Ratio performed in the past?

The current Current Ratio of Anavex Life Sciences Corp. (AVXL) is less than than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Anavex Life Sciences Corp. (AVXL) Current Ratio vs. Peers

How is AVXL’s Current Ratio compared to its peers?

Anavex Life Sciences Corp.’s Current Ratio is greater than Cassava Sciences, Inc. (4.07), greater than INmune Bio, Inc. (2.36), greater than BioVie Inc. (2.45), greater than Cognition Therapeutics, Inc. (3.07), greater than Annovis Bio, Inc. (1.24), greater than Iovance Biotherapeutics, Inc. (5.15), greater than Axsome Therapeutics, Inc. (2.48), greater than Novavax, Inc. (1.04), greater than Exelixis, Inc. (4.27), greater than TG Therapeutics, Inc. (3.58), less than Viking Therapeutics, Inc. (37.69), greater than Madrigal Pharmaceuticals, Inc. (8.72), greater than BioXcel Therapeutics, Inc. (2.35), greater than Reviva Pharmaceuticals Holdings, Inc. (0.41), greater than Eyenovia, Inc. (0.43), greater than TransCode Therapeutics, Inc. (1.25), greater than Kodiak Sciences Inc. (10.59),

Build a custom stock screener for Anavex Life Sciences Corp. (AVXL) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Anavex Life Sciences Corp. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Anavex Life Sciences Corp. (AVXL) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Anavex Life Sciences Corp. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.